The novel approach of this peptide represents a significant advance in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide075165.techionblog.com/42320314/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment